OpenArc Corporate Advisory’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
OpenArc Corporate Advisory's HALO Position: Q2 2026 in Review
OpenArc Corporate Advisory increased its Halozyme (HALO) stake by 1.6% in Q2 2026, buying an estimated $22K and bringing the position to 20,310 shares worth $1.59M. The position accounts for 0.02% of the portfolio, ranked #282.
OpenArc Corporate Advisory first reported a position in HALO in Q4 2025 and has held it in 3 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- OpenArc Corporate Advisory held 20,310 shares of Halozyme worth $1.59M as of Q2 2026.
- OpenArc Corporate Advisory bought 323 Halozyme shares in Q2 2026, an estimated $22K.
- Halozyme made up 0.02% of OpenArc Corporate Advisory's portfolio in Q2 2026, its #282 holding.
- OpenArc Corporate Advisory first reported a position in Halozyme in Q4 2025 and has held it in 3 quarters since.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.